Jiangsu Bioperfectus Technologies Co., Ltd. (SHA:688399)

SHA:688399 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	329.92	810.63	1,769	1,792	1,287	1,139
Short-Term Investments	-	30.56	-	-	-	-
Trading Asset Securities	1,628	1,138	694.81	1,015	623.33	298.22
Cash & Short-Term Investments	1,958	1,979	2,464	2,807	1,911	1,437
Cash Growth	-25.66%	-19.69%	-12.22%	46.90%	32.97%	73.26%
Accounts Receivable	55.68	53.89	108.71	610	343.63	159.84
Other Receivables	7.08	21.33	26.03	26.31	9.62	4.96
Receivables	62.76	75.23	134.74	636.31	353.25	164.81
Inventory	59.17	67.04	93.86	236.26	250.35	162.86
Prepaid Expenses	-	-	-	-	0.27	0.88
Other Current Assets	53.15	17.98	17	29.5	24.19	14.31
Total Current Assets	2,133	2,139	2,710	3,709	2,539	1,780
Property, Plant & Equipment	568.69	577.23	614.61	731.7	714.97	322.52
Long-Term Investments	222.29	224.15	112.64	116.28	122.9	96.31
Other Intangible Assets	26.86	27.45	29.88	27.41	26.82	26.59
Long-Term Deferred Tax Assets	73.87	75.01	80.39	91.63	19.27	15.08
Long-Term Deferred Charges	30.35	34.58	55.12	74.23	54.32	25.59
Other Long-Term Assets	814.02	662.23	303.99	140.6	22.18	11.72
Total Assets	3,869	3,740	3,906	4,891	3,499	2,278
Accounts Payable	23.19	17.56	29.17	327.8	132.5	79.22
Accrued Expenses	18.17	54.9	89.57	242.53	197.69	195.91
Short-Term Debt	366.15	227.69	156.94	84.89	150	50.05
Current Portion of Leases	2.04	5.64	7.82	8.38	7.32	-
Current Income Taxes Payable	2.33	0	0	85.37	32.51	47.28
Current Unearned Revenue	25.1	38.76	14.46	38.39	66.21	50.19
Other Current Liabilities	48.02	23.27	65.9	145.24	269.4	99.79
Total Current Liabilities	485	367.82	363.87	932.6	855.63	522.45
Long-Term Leases	9.71	7.22	8.7	10.52	6.9	-
Long-Term Unearned Revenue	61.17	64.28	78.24	90.82	86.82	90.25
Long-Term Deferred Tax Liabilities	-	-	0	16.24	3.53	0.48
Other Long-Term Liabilities	50	50	50.5	62.68	10	-
Total Liabilities	605.87	489.32	501.31	1,113	962.89	613.18
Common Stock	56.67	56.67	58.62	58.62	58.62	58.62
Additional Paid-In Capital	661.06	661.06	806.6	805.83	805.83	804.68
Retained Earnings	2,551	2,538	2,540	2,914	1,672	801.19
Comprehensive Income & Other	-4.98	-4.98	-	-	-	-
Shareholders' Equity	3,263	3,251	3,405	3,778	2,536	1,664
Total Liabilities & Equity	3,869	3,740	3,906	4,891	3,499	2,278
Total Debt	377.9	240.55	173.46	103.79	164.23	50.05
Net Cash (Debt)	1,580	1,738	2,291	2,703	1,747	1,387
Net Cash Growth	-31.59%	-24.11%	-15.26%	54.77%	25.93%	67.22%
Net Cash Per Share	23.97	26.06	39.10	46.11	29.80	23.66
Filing Date Shares Outstanding	56.67	56.67	58.62	58.62	58.62	58.62
Total Common Shares Outstanding	56.67	56.67	58.62	58.62	58.62	58.62
Working Capital	1,648	1,771	2,346	2,777	1,683	1,257
Book Value Per Share	57.59	57.36	58.09	64.45	43.27	28.39
Tangible Book Value	3,237	3,223	3,375	3,751	2,510	1,638
Tangible Book Value Per Share	57.11	56.88	57.58	63.98	42.81	27.94
Buildings	-	553.68	551.68	537.05	506.36	-
Machinery	-	237.44	236.62	313.41	263.97	145.23
Construction In Progress	-	4.94	1.53	16.99	20.72	238.63

Source: S&P Global Market Intelligence. Standard template. Financial Sources.